MetLife Investment Management’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $288K | Hold |
32,682
| – | – | ﹤0.01% | 1981 |
|
|
2025
Q1 | $245K | Sell |
32,682
-120
| -0.4% | -$899 | ﹤0.01% | 2095 |
|
|
2024
Q4 | $274K | Buy |
32,802
+9,936
| +43% | +$82.9K | ﹤0.01% | 2132 |
|
|
2024
Q3 | $159K | Buy |
22,866
+1,717
| +8% | +$11.9K | ﹤0.01% | 2408 |
|
|
2024
Q2 | $104K | Buy |
21,149
+9,357
| +79% | +$45.8K | ﹤0.01% | 2587 |
|
|
2024
Q1 | $68.4K | Sell |
11,792
-6,672
| -36% | -$38.7K | ﹤0.01% | 2671 |
|
|
2023
Q4 | $121K | Hold |
18,464
| – | – | ﹤0.01% | 2511 |
|
|
2023
Q3 | $89K | Hold |
18,464
| – | – | ﹤0.01% | 2633 |
|
|
2023
Q2 | $94.2K | Buy |
+18,464
| New | +$94.2K | ﹤0.01% | 2714 |
|
|
2021
Q4 | – | Sell |
-2,415
| Closed | -$22.5K | – | 2557 |
|
|
2021
Q3 | $22.5K | Sell |
2,415
-9,185
| -79% | -$85.7K | ﹤0.01% | 2558 |
|
|
2021
Q2 | $149K | Buy |
+11,600
| New | +$149K | ﹤0.01% | 2329 |
|